SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-006912
Filing Date
2022-03-22
Accepted
2022-03-22 16:06:03
Documents
17
Period of Report
2022-03-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20220321_8k.htm   iXBRL 8-K 32399
2 EXHIBIT 10.1 ex_349567.htm EX-10.1 73022
3 EXHIBIT 99.1 ex_349568.htm EX-99.1 11251
8 logo2.jpg GRAPHIC 21684
9 logo.jpg GRAPHIC 12662
  Complete submission text file 0001437749-22-006912.txt   324382

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arav-20220321.xsd EX-101.SCH 3601
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20220321_def.xml EX-101.DEF 11919
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20220321_lab.xml EX-101.LAB 15966
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20220321_pre.xml EX-101.PRE 12130
11 EXTRACTED XBRL INSTANCE DOCUMENT arav20220321_8k_htm.xml XML 2655
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 22759557
SIC: 2834 Pharmaceutical Preparations